HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia-Reference-Cited by-同舟云学术

HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia

Published:2018-08 Issue:8 Volume:13 Page:575-584
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Pinto Angie N¹,Hawke Karen²,Castley Allison³,Chibo Doris⁴,Giallonardo Francesca Di¹,Cooper Craig⁵,Sawleshwarkar Shailendra⁶,Kelleher Anthony¹,Dwyer Dominic E⁷⁸

Affiliation:

1. The Kirby Institute, The University of New South Wales, UNSW Sydney, Australia

2. South Australian Health & Medical Research Institute, Adelaide, South Australia

3. PathWest, Clinical Immunology, Department of Health, Murdoch, Western Australia, Australia

4. HIV Characterization Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, Victoria, Australia

5. Positive Life NSW, Sydney, New South Wales, Australia

6. The University of Sydney, Faculty of Medicine & Health, Westmead Clinical School, Western Sydney Sexual Health Centre, Parramatta, New South Wales, Australia

7. NSWHP-ICPMR, Westmead Hospital, Westmead, NSW, Australia

8. Westmead Clinical School, University of Sydney, Westmead, Australia

Abstract

Australia has maintained a low prevalence of HIV, with a mainly concentrated epidemic and successful public health response. With the widespread availability of HIV genotyping for resistance testing, and development of phylogenetic methodologies, the field of molecular epidemiology has evolved a deeper understanding of diversity and transmission dynamics of HIV. Studies combining HIV genotype with epidemiological data have allowed insights to be gained into the changing subtype diversity, rates of transmitted drug resistance and transmission networks of HIV in Australia. This review provides an overview of HIV molecular epidemiology studies in Australia.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2018-0031

Reference66 articles.

1. Molecular Epidemiology of Tuberculosis

2. The Origin of the Haitian Cholera Outbreak Strain

3. Australian Commission on Safety and Quality in Health Care. National alert system for critical antimicrobial resistances: CARAlert. 2018(12/2/2018), Report (2017). www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/what-is-aura/national-alert-system-for-critical-antimicrobial-resistances-caralert/.

4. Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study

5. The Kirby Institute. Annual surveillance report of HIV, viral hepatitis, STIs 2017 (2017). https://kirby.unsw.edu.au/report/annual-surveillance-report-hiv-viral-hepatitis-and-stis-australia-2017.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular epidemiology to aid virtual elimination of HIV transmission in Australia;Virus Research;2024-03

2. Laboratory diagnosis of HIV: a contemporary overview in the Australian context;Pathology;2023-08

3. HIV-1 transmitted drug resistance in Brighton, UK, from 2014 to 2020;International Journal of STD & AIDS;2020-12-16

4. HIV-1 subtype variability and transmitted drug resistance in a culturally diverse population in Western Sydney, New South Wales, Australia;Sexual Health;2020